logo

For the Inventor, By the Inventor

Woodcliff Lake, NJ, United States of America

Eagle Pharmaceuticals, Inc.


USPTO Granted Patents = 38


Trademarks = 4

Forward Citations = 302

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Nagesh R Palepu (17 out of 33 patents)

silverMedal Philip Christopher Buxton (12 out of 21 patents)

bronzeMedal Srikanth Sundaram (10 out of 21 patents)

4.  Steven L Krill (5 out of 17 patents)

5.  Feng-Jing Chen (5 out of 13 patents)

6.  Adrian Hepner (4 out of 7 patents)

7.  Bulusu Bhanu Teja (3 out of 3 patents)

8.  Rama Abu Shmeis (3 out of 7 patents)

9.  Nageswara R Palepu (3 out of 24 patents)

10.  Scott L Tarriff (3 out of 3 patents)

11.  Charles Wescott (2 out of 4 patents)

12.  Rajeshwar Motheram (2 out of 14 patents)

13.  Gopal Krishna (2 out of 8 patents)

14.  Praful Shah (2 out of 2 patents)

15.  Tara Jaskowski (2 out of 2 patents)


Core Competencies:
Bendamustine
Pemetrexed
SARS-CoV-2
Fulvestrant
Daptomycin
Bivalirudin
Argatroban
Pharmaceutical Compositions
Formulations
Treatment Methods
Storage Stability
Severe Respiratory Syndrome

38 patents:

1. 12605364 - Methods of treating SARS-CoV-2 infections (2026-04-21),
2. 12582633 - Methods of treating severe acute respiratory syndrome (2026-03-24),
3. 12370199 - Fulvestrant formulations and methods of their use (2025-07-29),
4. 12350339 - Fulvestrant formulations (2025-07-08),
5. 12350257 - Formulations of bendamustine (2025-07-08),
6. 12343333 - Formulations of bendamustine (2025-07-01),
7. 12186427 - Fulvestrant formulations and methods of their use (2025-01-07),
8. 12138248 - Formulations of bendamustine (2024-11-12),
9. 12115164 - Pemetrexed formulations (2024-10-15),
10. 11872214 - Formulations of Bendamustine (2024-01-16),
11. 11844783 - Formulations of bendamustine (2023-12-19),
12. 11793813 - Pemetrexed formulations (2023-10-24),
13. 11590077 - Fulvestrant formulations and methods of their use (2023-02-28),
14. 11179468 - Fulvestrant formulations (2021-11-23),
15. 11103483 - Formulations of bendamustine (2021-08-31),
Company Overview
Eagle Pharmaceuticals, Inc. is a biopharmaceutical company based in Woodcliff Lake, New Jersey, specializing in the development and commercialization of innovative injectable products. The company focuses on enhancing the delivery of existing therapies and creating new formulations that improve patient outcomes. With a commitment to addressing unmet medical needs, Eagle Pharmaceuticals leverages its expertise in drug formulation and development to provide high-quality solutions in the healthcare sector.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

38 Patents

#1 in Woodcliff Lake, NJ

#367 in New Jersey

#9,027 in US

#17,844 in the World

Woodcliff Lake, NJ (US)
Woodcliff Lake, NJ, United States of America

Eagle Pharmaceuticals, Inc.

Forward Citations = 302

16 inventors:

goldMedal Nagesh R Palepu (17 out of 33 patents)

silverMedal Philip Christopher Buxton (12 out of 21 patents)

bronzeMedal Srikanth Sundaram (10 out of 21 patents)

4.  Steven L Krill (5 out of 17 patents)

5.  Feng-Jing Chen (5 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Eagle Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/eagle-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…